1105106

Source:http://linkedlifedata.com/resource/pubmed/id/1105106

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists.
Subject	Predicate	Object	Context
pubmed-article:1105106	rdf:type	pubmed:Citation	lld:pubmed
pubmed-article:1105106	lifeskim:mentions	umls-concept:C0030705	lld:lifeskim
pubmed-article:1105106	lifeskim:mentions	umls-concept:C0008976	lld:lifeskim
pubmed-article:1105106	lifeskim:mentions	umls-concept:C0024977	lld:lifeskim
pubmed-article:1105106	lifeskim:mentions	umls-concept:C0497406	lld:lifeskim
pubmed-article:1105106	pubmed:issue	14	lld:pubmed
pubmed-article:1105106	pubmed:dateCreated	1976-2-13	lld:pubmed
pubmed-article:1105106	pubmed:abstractText	A 12-week double-blind trial involving 50 patients from a suburban general practice showed a highly significant loss of weight in the group taking 2 mg of mazindol (Sanorex) per day.	lld:pubmed
pubmed-article:1105106	pubmed:language	eng	lld:pubmed
pubmed-article:1105106	pubmed:journal	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:1105106	pubmed:citationSubset	IM	lld:pubmed
pubmed-article:1105106	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:1105106	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:1105106	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:1105106	pubmed:status	MEDLINE	lld:pubmed
pubmed-article:1105106	pubmed:month	Oct	lld:pubmed
pubmed-article:1105106	pubmed:issn	0025-729X	lld:pubmed
pubmed-article:1105106	pubmed:author	pubmed-author:HeberK RKR	lld:pubmed
pubmed-article:1105106	pubmed:issnType	Print	lld:pubmed
pubmed-article:1105106	pubmed:day	4	lld:pubmed
pubmed-article:1105106	pubmed:volume	2	lld:pubmed
pubmed-article:1105106	pubmed:owner	NLM	lld:pubmed
pubmed-article:1105106	pubmed:authorsComplete	Y	lld:pubmed
pubmed-article:1105106	pubmed:pagination	566-7	lld:pubmed
pubmed-article:1105106	pubmed:dateRevised	2007-11-15	lld:pubmed
pubmed-article:1105106	pubmed:meshHeading	pubmed-meshheading:1105106-...	lld:pubmed
pubmed-article:1105106	pubmed:meshHeading	pubmed-meshheading:1105106-...	lld:pubmed
pubmed-article:1105106	pubmed:meshHeading	pubmed-meshheading:1105106-...	lld:pubmed
pubmed-article:1105106	pubmed:meshHeading	pubmed-meshheading:1105106-...	lld:pubmed
pubmed-article:1105106	pubmed:meshHeading	pubmed-meshheading:1105106-...	lld:pubmed
pubmed-article:1105106	pubmed:meshHeading	pubmed-meshheading:1105106-...	lld:pubmed
pubmed-article:1105106	pubmed:meshHeading	pubmed-meshheading:1105106-...	lld:pubmed
pubmed-article:1105106	pubmed:meshHeading	pubmed-meshheading:1105106-...	lld:pubmed
pubmed-article:1105106	pubmed:year	1975	lld:pubmed
pubmed-article:1105106	pubmed:articleTitle	Double-blind trial of mazindol in overweight patients.	lld:pubmed
pubmed-article:1105106	pubmed:publicationType	Journal Article	lld:pubmed
pubmed-article:1105106	pubmed:publicationType	Clinical Trial	lld:pubmed
pubmed-article:1105106	pubmed:publicationType	Controlled Clinical Trial	lld:pubmed